MedTrace Logo

Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU

NCT02917811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2017-03-30

No results posted yet for this study

Summary

The aim of this study is to verify if high values of RDW are useful prognostic marker for ICU mortality and 90-days mortality. Moreover, we will investigate the prognostic value of RDW in specific subgroup population with some clinical characteristic wich may modify RDW baseline values, i.e. transfused patients or patients with high markers of hemolysis

Conditions

  • Blood Transfusion
  • Biochemical Marker

Sponsors & Collaborators

  • Università degli Studi di Ferrara

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-10-31
Completion
2016-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02917811 on ClinicalTrials.gov